Intestinal Obstruction: Clinical Trials

4 trials for Intestinal Obstruction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Unknown 4

Follow Intestinal Obstruction: new trials by email Literature Review of Intestinal Obstruction trials Research Report on Intestinal Obstruction

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial
Rifaximin oral tablet, Placebo oral tablet - Chronic Intestinal Pseudo-obstruction
Phase 2UnknownYokohama City University122019-12-252021-06-21
Use of Gastrografin in the Management of Fecal Impaction in Patients With Severe Chronic Constipation
Gastrografin, enemas - Fecal Impaction
Phase 2UnknownJinling Hospital, China832015-04-012017-08-09
Stimulation of the Efferent Loop Before Loop Ileostomy Closure
efferent limb stimulation - Ileostomy - Stoma, Ileostomy; Complications
Phase 2UnknownHospital de Basurto1402014-11-202018-02-07
Daikenchuto for Intestinal Dysmotility and Prevention of Postoperative Paralytic Ielus After Pancreaticoduodenectomy
Oral/enteral TJ-100 solution, Oral/enteral placebo solution - Paralytic Ileus
Phase 2UnknownWakayama Medical University2202012-08-012013-12-18

Narrower conditions

Intestinal Pseudo-Obstruction (2)  ·  Fecal Impaction (1)  ·  Ileus (1)  ·  Scleroderma, Systemic (1)

Broader conditions

Digestive System Diseases (4)  ·  Gastrointestinal Diseases (4)  ·  Intestinal Diseases (4)  ·  Ileus (2)  ·  Connective Tissue Diseases (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Enema (1)  ·  Rifaximin (1)

Sponsors

Hospital de Basurto (1)  ·  Jinling Hospital, China (1)  ·  Wakayama Medical University (1)  ·  Yokohama City University (1)

Countries

Japan (2)  ·  China (1)  ·  Spain (1)

Top investigators

Hiroki Yamaue, M.D., Ph.D. (1)  ·  Ning Li, MD (1)

Results publications

PMID 26747224, PMID 30333892